Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study

Leukemia Research

Volumn 31, Issue 1, 2007, Pages 75-82

  Zhang, Daohai ^a,c   Tai, Yan Chin ^b   Wong, Ching Ho Stephen ^b   Tai, Lee Kian ^c   Koay, Evelyn Siew Chuan ^a,c   Chen, Chien Shing ^a,b,c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell cycle arrest; Genistein; Leukemia HL 60; Proteomics; Tyrosine kinase

Indexed keywords

CHAPERONE; GENISTEIN; HEAT SHOCK PROTEIN 70; PROTEIN TYROSINE KINASE INHIBITOR; RIBONUCLEOPROTEIN; STATHMIN;

ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA PROCESSING;

ANTICARCINOGENIC AGENTS; CELL DIVISION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; GENISTEIN; HL-60 CELLS; HUMANS; KINETICS; MASS SPECTROMETRY; NEOPLASM PROTEINS; PROTEIN-TYROSINE KINASES; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RIBONUCLEOPROTEINS; TRYPSIN;

EID: 33750719622     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.02.026     Document Type: Article

References (40)

1. Akiyama T., Ishida J., Nakagawa S., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
2. Spinozzi F., Pagliacci M.C., Migliorati G., et al. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leukemia Res 18 (1994) 431-439
3. Sarkar F.H., and Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metast Rev 21 (2002) 265-280
4. Ouchi H., Ishiguro H., Ikeda N., et al. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Int J Urol 12 (2005) 73-80
5. 3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 241 (2005) 49-61
6. Baxa D.M., Luo X., and Yoshimura F.K. Genistein induces apoptosis in T lymphoma cells via mitochondrial damage. Nutr Cancer 51 (2005) 93-101
7. Park S.S., Kim Y.N., Jeon Y.K., et al. Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma. Cancer Chemother Pharmacol 56 (2005) 271-278
8. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
9. Magee P.J., and Rowland I.R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91 (2004) 513-531
10. Zhou Y., and Lee A.S. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J Natl Cancer Instit 90 (1998) 381-388
11. Huang X., Chen S., Xu L., et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65 (2005) 3470-3478
12. Dave B., Eason R.R., Till S.R., et al. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26 (2005) 1793-1803
13. Gong L., Li Y., Nedeljkovic-Kurepa A., et al. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22 (2003) 4702-4709
14. Kazi A., Daniel K.G., Smith D.M., et al. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol 66 (2003) 965-976
15. Katdare M., Osborne M., and Telang N.T. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 21 (2002) 809-815
16. Jin Z., and MacDonald R.S. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132 (2002) 3186-3190
17. Bai J., Sata N., Nagai H., et al. Genistein-induced changes in gene expression in Panc 1 cells at physiological concentrations of genistein. Pancreas 29 (2004) 93-98
18. Wang J., Eltoum I.E., and Lamartiniere C.A. Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 219 (2004) 171-180
19. Hwang J.T., Ha J., and Park O.J. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 332 (2005) 433-440
20. Gercel-Taylor C., Feitelson A.K., and Taylor D.D. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res 24 (2004) 795-800
21. Tamura S., Bito T., Ichihashi M., et al. Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Pigment Cell Res 16 (2003) 470-476
22. Traganos F., Ardelt B., Halko N., et al. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 52 (1992) 6200-6208
23. Li W., and Weber G. Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells. Life Sci 63 (1998) 1975-1981
24. Lee R., Kim Y.J., Lee Y.J., et al. The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology 195 (2004) 87-95
25. Zhang D., Tai L.K., Wong L.L., et al. Proteomics of breast cancer: enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 5 (2005) 1797-1805
26. Patry C., Lemieux B., Wellinger R.J., et al. Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines. Mol Cancer Ther 3 (2004) 1193-1199
27. Kim J.H., Paek K.Y., Ha S.H., et al. A cellular RNA-binding protein enhances internal ribosomal entry site-dependent translation through an interaction downstream of the hepatitis C virus polyprotein initiation codon. Mol Cell Biol 24 (2004) 7878-7890
28. Holcik M., Gordon B.W., and Korneluk R.G. The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol Cell Biol 23 (2003) 280-288
29. Lee S.Y., Park J.H., Kim S., et al. A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks. Biochem J 388 (2005) 7-15
30. Honore B., Baandrup U., and Vorum H. Heterogeneous nuclear ribonucleoproteins F and H/H′ show differential expression in normal and selected cancer tissues. Exp Cell Res 294 (2004) 199-209
31. Seong J.K., Kim D.K., Choi K.H., et al. Proteomic analysis of the cellular proteins induced by adaptive concentrations of hydrogen peroxide in human U937 cells. Exp Mol Med 34 (2002) 374-378
32. Hu W., Wu W., Verschraegen C.F., et al. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics 3 (2003) 1904-1911
33. Zhao Z.G., and Shen W.L. Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901. World J Gastroenterol 11 (2005) 73-78
34. Lau A.T., He Q.Y., and Chiu J.F. A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem J 382 (2004) 641-650
35. Cecconi D., Astner H., Donadelli M., et al. Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2′-deoxycytidine. Electrophoresis 24 (2003) 4291-4303
36. Alli E., Bash-Babula J., Yang J.M., et al. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62 (2002) 6864-6869
37. Kip1-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7 (2005) 51-63
38. Jeha S., Luo X.N., Beran M., et al. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res 56 (1996) 1445-1450
39. Takai Y., Sasaki T., and Matozaki T. Small GTP-binding proteins. Physiol Rev 81 (2001) 153-208
40. Junutula J.R., De Maziere A.M., Peden A.A., et al. Rab14 is involved in membrane trafficking between the Golgi complex and endosomes. Mol Biol Cell 15 (2004) 2218-2229